• Soltero-Martínez, J. F. Armando
• Villanueva, Adrián
• Gutiérrez-Saucedo, Ramón A.
• Gómez-López, Julio C.
• Taboada, Pablo
• Topete, Antonio
• Jasso-Gastinel, Carlos F.
• Figueroa Ochoa, Edgar Benjamin
• Mendizabal, Eduardo

Abstract

<jats:p>The potential application of biodegradable and biocompatible polymeric micelles formed by Pluronic F127 and P104 as nanocarriers of the antineoplastic drugs docetaxel (DOCE) and doxorubicin (DOXO) is presented in this work. The release profile was carried out under sink conditions at 37 °C and analyzed using the Higuchi, Korsmeyer–Peppas, and Peppas–Sahlin diffusion models. The cell viability of HeLa cells was evaluated using the proliferation cell counting kit CCK-8 assay. The formed polymeric micelles solubilized significant amounts of DOCE and DOXO, and released them in a sustained manner for 48 h, with a release profile composed of an initial rapid release within the first 12 h followed by a much slower phase the end of the experiments. In addition, the release was faster under acidic conditions. The model that best fit the experimental data was the Korsmeyer–Peppas one and denoted a drug release dominated by Fickian diffusion. When HeLa cells were exposed for 48 h to DOXO and DOCE drugs loaded inside P104 and F127 micelles, they showed lower IC50 values than those reported by other researchers using polymeric nanoparticles, dendrimers or liposomes as alternative carriers, indicating that a lower drug concentration is needed to decrease cell viability by 50%.</jats:p>

Topics

• nanoparticle
• impedance spectroscopy
• phase
• experiment
• dendrimer